Vaccine makers doing right to look to adjust COVID-19 jabs - WHO
Reuters
Published Dec 03, 2021 07:03AM ET
Updated Dec 03, 2021 10:21AM ET
GENEVA (Reuters) - It is "commendable" that makers of COVID-19 vaccines are planning for the "likelihood" of needing to adjust their products to protect against the Omicron variant, a World Health Organization (WHO) spokesperson said on Friday.
Christian Lindmeier, speaking at a U.N. briefing in Geneva, said the agency was still studying the transmissibility and severity of the new variant, first reported in southern Africa.
"It is very commendable that vaccine manufacturers already start planning ahead and plan for the likelihood for having to adjust the existing vaccine," he said. "That's good not just to wait until the final alarm bell rings."
(This story officially corrects first paragraph to show WHO spokesman meant to say he was commending companies for looking to adjust vaccines, not recommending that they do so)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.